Ad
related to: food and drug administration ph
Search results
Why Is Insmed (INSM) Stock Up 134% Today?
InvestorPlace· 7 days agoInsmed (NASDAQ:INSM) stock is rising higher on Tuesday after the company announced positive results from a Phase 3 clinical trial of brensocatib in...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 4 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely
How PherDal’s At-Home Insemination Kit Helps People Conceive Safely
Forbes· 5 days agoAccording to Dr. Jennifer Hintzsche, CEO of PherDal Fertility Science, unexplained infertility...
Zyn is following Big Tobacco's playbook for teens
Medical Xpress· 22 hours agoZyn's synthetic nicotine offers the kick of a cigarette or dip without the cancer-causing smoke and chemicals of tobacco, packaged in a pouch that can be...
Kourtney Kardashian Barker Wants Your Legs to Have the Smoothest Summer Ever
ELLE· 15 hours agoKourtney Kardashian Barker and I have been trying to lock down a time to connect for days. The multi-hyphenate’s chaotic schedule has been even busier lately, given the birth ...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Woonsocket Call· 4 days ago(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration ...
Don’t Sweat It! The Best Deodorants for All-Day Protection
Vogue· 2 days agoNo matter what the best deodorant looks like for you—baking soda enthusiast, rollerball only, or the...
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer - Jazz...
Benzinga· 6 days agoTarget Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ locally advanced or metastatic biliary tract
Study shows effectiveness of updated COVID-19 vaccines wanes moderately over time, is lower against...
Medical Xpress· 5 days agoPublished in the New England Journal of Medicine, the study found that COVID-19 boosters targeting the XBB.1.5 subvariants were most effective one month after receiving one. After four weeks ...
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug...
Digital Journal· 6 days ago(OTCQB:FLHLF)(CBOE CA:FH)(FSE:7QS) to develop novel, natural prescription medicines derived from plants for mental health indications, has been expanded to cover ethnobotanical know-how related ...